Immunology, Infection and Inflammation

Tumor cells often involve changes that should make them appear ‘foreign’ to the body’s immune system. Thus, these tumors must develop strategies to either suppress or evade the patient’s immune system. There is tremendous therapeutic potential in working to strengthen the patient’s immune response to the tumor, as well as the potential for artificially inducing an appropriate immune response against a tumor. These types of therapies are often very effective as an adjunct to more traditional therapies and add another valuable tool to the translational arsenal.

Augusto Ochoa, M.D. – LSU

Diego Aviles – LSU

John Estrada, MD – LSU

Qian Jin Zhang – Xavier

Michael Lan – LSU

Madhwa H. G. Raj, MSc, PhD – LSU

Cleveland Moore – LSU

Alistair Ramsay – LSU

Judd Shellito – LSU

Joy Sturtevant – LSU

Julia Volaufova – LSU

Ivona V. Pandrea, M.D., Ph.D. – Tulane

Jovany Zabaleta, Ph.D. – LSU

Shulin Li – LSU

Dario Marchetti – LSU

Michael Hagensee, M.D. – LSU

Seth Pincus – LSU

Samuel J. Landry, Ph.D. – Tulane

Srikanta Dash, Ph.D. – Tulane

Vecihi Batuman, M.D. – Tulane

Yan Cui, Ph.D. – LSU